Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia.

Saved in:
Bibliographic Details
Title: Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia.
Authors: Wu A; Department of Experimental Medicine, University of British Columbia, Vancouver, BC, Canada.; BC Children's Hospital Research Institute, Vancouver, BC, Canada., Anderson H; Medical Oncology, BC Cancer, Provincial Health Services Authority, Vancouver, BC, Canada., Hughesman C; Cancer Genetics and Genomics Laboratory, BC Cancer, Provincial Health Services Authority, Vancouver, BC, Canada., Young S; Cancer Genetics and Genomics Laboratory, BC Cancer, Provincial Health Services Authority, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada., Lohrisch C; Medical Oncology, BC Cancer, Provincial Health Services Authority, Vancouver, BC, Canada., Ross CJD; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada., Carleton BC; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.; Therapeutic Evaluation Unit, Provincial Health Services Authority, Vancouver, BC, Canada.
Source: Frontiers in pharmacology [Front Pharmacol] 2023 Sep 08; Vol. 14, pp. 1257745. Date of Electronic Publication: 2023 Sep 08 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1663-9812
DOI:10.3389/fphar.2023.1257745